Medidata Rave
Medidata, a Dassault Systèmes company, provides cloud-based software and data analytics platforms for clinical trials, including Medidata Rave for electronic data capture and clinical data management, serving pharmaceutical, biotechnology, medical device companies, and contract research organizations on a subscription and services basis.
- Revenue
- $1B+
- Employees
- 1,001 - 5,000
- Founded
- 1999
- Headquarters
- New York City, United States of America
Medidata Rave customers on Arbolus
Customers who reviewed Medidata Rave
Seniority of Medidata Rave customers
The largest group of people who reviewed Medidata Rave holds Director roles (50%), followed by Manager (30%) and C-Suite (20%).
- Director 50%
- Manager 30%
- C-Suite 20%
Customers sample
Employer names and spend open in the full report, along with the other 17 customers.
What 20 Arbolus experts think of Medidata Rave
Overall sentiment: Positive
80% of respondents are Promoters, 13.3% are Passives, and 6.7% are Detractors, resulting in an NPS of 73.3. All respondents with disclosed renewal intent (100%) plan to renew. 80% of users have been on the platform for more than one year, indicating strong stickiness. Key feedback themes include high data quality, real-time visibility, and robust compliance, with cost and complexity as the main drawbacks.
Everything 20 customers told us about Medidata Rave.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
70 Net Promoter Score, from 20 scored reviews- Promoters 15
- Passives 4
- Detractors 1
Praised
- AI and Cost Effectiveness
- Data Quality and Real-Time Visibility
Criticised
- Cost and Complexity
- Competitive Threat from Integrated CROs
What Medidata Rave customers say
Data Quality and Real-Time Visibility
“I find that Medidata Rave standardizes and centralizes clinical data collection, allowing direct data entry, improving data quality, and providing real-time visibility for sponsors and data managers.”
AI and Cost Effectiveness
“I believe cost effectiveness is something we will be closely looking at in the future as EDC becomes more commoditized and as AI and EHR/EMR integrations improve.”
Cost and Complexity
“I think the disadvantages are primarily cost, complexity, and the significant upfront configuration and ongoing administration required, especially for complex protocols.”
Renewal intent
Plan to renew 100%Plan to renew, by seniority
- 100% 2 answers
- 100% 5 answers
- 100% 1 answer
- 8.5/10 Average score from customers who will renew
Top alternatives
Most weighed by Medidata Rave customersReport
For people who use Medidata Rave
Do you use Medidata Rave at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 20 customers of Medidata Rave have already contributed
Takes a few minutes. Your identity stays anonymous.